This invention relates to an sgRNA targeting the TGFBI
gene, a vector, and their applications. The multiple sgRNAs designed in this invention can specifically target the TGFBI
gene and mediate efficient and specific editing by nucleases or base editors. By disrupting the expression process of the TGFBI
gene, it can achieve the treatment of corneal dystrophy (CD) caused by TGFBI
gene mutation, with the advantages of excellent
therapeutic effect and low treatment frequency, and has potential application prospects.